[go: up one dir, main page]

EA201070250A1 - Противомикробный парентеральный состав - Google Patents

Противомикробный парентеральный состав

Info

Publication number
EA201070250A1
EA201070250A1 EA201070250A EA201070250A EA201070250A1 EA 201070250 A1 EA201070250 A1 EA 201070250A1 EA 201070250 A EA201070250 A EA 201070250A EA 201070250 A EA201070250 A EA 201070250A EA 201070250 A1 EA201070250 A1 EA 201070250A1
Authority
EA
Eurasian Patent Office
Prior art keywords
microbial
parenteral composition
parenteral
composition
funds
Prior art date
Application number
EA201070250A
Other languages
English (en)
Other versions
EA017702B1 (ru
Inventor
Лих-Хуей Ли
По-Ли Ву
Эркуан Сун
Чи-Син Ричард Кинг
Original Assignee
Тайджен Байотекнолоджи Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тайджен Байотекнолоджи Ко., Лтд. filed Critical Тайджен Байотекнолоджи Ко., Лтд.
Publication of EA201070250A1 publication Critical patent/EA201070250A1/ru
Publication of EA017702B1 publication Critical patent/EA017702B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Данное изобретение относится к парентеральному составу, содержащему эффективное количество соединения формулы I, указанного в описании и обеспечивающего изотоничность средства. Также описан способ лечения инфекционного заболевания посредством введения данного состава индивидууму посредством парентеральной инъекции или инфузии.
EA201070250A 2007-08-09 2008-08-05 Способ лечения инфекционного заболевания EA017702B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/836,241 US8658183B2 (en) 2007-08-09 2007-08-09 Antimicrobial parenteral formulation
PCT/US2008/072210 WO2009023473A2 (en) 2007-08-09 2008-08-05 Antimicrobial parenteral formulation

Publications (2)

Publication Number Publication Date
EA201070250A1 true EA201070250A1 (ru) 2010-10-29
EA017702B1 EA017702B1 (ru) 2013-02-28

Family

ID=40347132

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070250A EA017702B1 (ru) 2007-08-09 2008-08-05 Способ лечения инфекционного заболевания

Country Status (12)

Country Link
US (1) US8658183B2 (ru)
EP (1) EP2185143B1 (ru)
JP (1) JP5805389B2 (ru)
KR (1) KR101313858B1 (ru)
AU (1) AU2008287144C1 (ru)
CA (1) CA2693041C (ru)
DK (1) DK2185143T3 (ru)
EA (1) EA017702B1 (ru)
ES (1) ES2402055T3 (ru)
TW (1) TWI391135B (ru)
WO (1) WO2009023473A2 (ru)
ZA (1) ZA201000250B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008358909B2 (en) * 2008-07-01 2012-12-13 Taigen Biotechnology Co., Ltd. Treatment of antibiotic-resistant bacteria infection
EP2362775B1 (en) 2008-11-20 2015-08-05 GlaxoSmithKline LLC Chemical compounds
US9359275B2 (en) * 2012-02-23 2016-06-07 Children's Medical Center Corporation Natural product antibiotics and analogs thereof
AR091567A1 (es) * 2012-06-27 2015-02-11 Takeda Pharmaceutical Preparacion liquida, metodo, kit de inyeccion
CN103159793B (zh) * 2013-03-20 2016-08-03 太景生物科技股份有限公司 一种奈诺沙星螯合物的制备方法
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
KR20140119363A (ko) * 2013-03-29 2014-10-10 에스케이케미칼주식회사 보리코나졸이 함유된 안정화된 조성물
EP3677687A4 (en) 2017-09-01 2021-05-26 The Kitasato Institute NEW COMPOSITION WITH THERAPEUTIC EFFECT AGAINST INFECTIONS DUE TO THE MYCOBACTERIUM-AVIUM COMPLEX AND THE PROCESS FOR THEIR PRODUCTION
MX2023013984A (es) * 2021-05-26 2023-12-12 Daewoong Pharmaceutical Co Ltd Nueva formulacion para inyeccion que comprende 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4-metoxi-1h- pirrol-3-il)-n-metilmetanamina.
CN114437026A (zh) * 2021-10-26 2022-05-06 浙江医药股份有限公司新昌制药厂 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
ID24703A (id) * 1997-09-15 2000-08-03 Procter & Gamble Kuinolon antimikroba, komposisi dan penggunaannya
US6348624B1 (en) 1998-01-09 2002-02-19 The Procter & Gamble Co. Process for making certain benzoic acid compounds
RU2256654C2 (ru) * 1999-01-22 2005-07-20 Кирин Бир Кабусики Кайся Хинолиновые и хиназолиновые производные
PL207394B1 (pl) 2000-12-14 2010-12-31 Procter & Gamble Sposób wytwarzania chinolonów i naftyrydyn
US6878713B2 (en) * 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
ATE507219T1 (de) 2006-03-28 2011-05-15 Warner Chilcott Co Llc Malatsalze und polymorphe von (3s,5s)-7-ä3-amino- 5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro 8-methoxy-4-oxo-3-chinolincarbonsäure
JP2009531418A (ja) 2006-03-28 2009-09-03 ザ プロクター アンド ギャンブル カンパニー キノロン中間体調製のためのカップリング方法
WO2007110836A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A hydride reduction process for preparing quinolone intermediates

Also Published As

Publication number Publication date
US20090042932A1 (en) 2009-02-12
AU2008287144A1 (en) 2009-02-19
EP2185143B1 (en) 2013-01-02
WO2009023473A2 (en) 2009-02-19
EA017702B1 (ru) 2013-02-28
ZA201000250B (en) 2010-09-29
EP2185143A4 (en) 2011-09-07
JP2010535797A (ja) 2010-11-25
DK2185143T3 (da) 2013-03-04
CA2693041C (en) 2016-11-08
TWI391135B (zh) 2013-04-01
CA2693041A1 (en) 2009-02-19
JP5805389B2 (ja) 2015-11-04
ES2402055T3 (es) 2013-04-26
HK1142521A1 (en) 2010-12-10
KR101313858B1 (ko) 2013-09-30
WO2009023473A9 (en) 2009-04-23
AU2008287144C1 (en) 2015-01-22
US8658183B2 (en) 2014-02-25
TW200922579A (en) 2009-06-01
KR20100067650A (ko) 2010-06-21
EP2185143A2 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
EA201070250A1 (ru) Противомикробный парентеральный состав
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
EA201290919A1 (ru) Индазольные соединения и их применение
EA201490396A1 (ru) Ингибиторы репликации вирусов гриппа
TN2009000481A1 (en) Novel peptide inhibitors of hepatitis c virus replication
EA201001639A1 (ru) Композиции и способы их получения и применения
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
DK1885187T3 (da) Fremgangsmåde til behandling af lægemiddelresistent cancer
CY1115262T1 (el) Ανταγωνιστες trpv1 και χρησεις αυτων
MX2009011867A (es) Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
BRPI1009637A2 (pt) composto, composição e uso de um composto
TW200740773A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
EA201100119A1 (ru) Химические соединения 251
EA200870060A1 (ru) Эмульсия бутилфталида для внутривенного введения и ее применение
EA201290128A1 (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
EA200970512A1 (ru) Лечение по поводу множественной миеломы
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων
MX2012003171A (es) Novedosos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
EA200970375A1 (ru) Соединения и способы лечения вируса гепатита с
UA107562C2 (uk) Спосіб лікування псоріазу
WO2009134616A3 (en) Novel inhibitors of hepatitis c virus replication
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей

Legal Events

Date Code Title Description
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state
TK4A Corrections in published eurasian patents